Literature DB >> 30838303

Minimal Clinically Important Difference for UPDRS-III in Daily Practice.

Álvaro Sánchez-Ferro1,2,3,4, Michele Matarazzo1,2,3,5, Pablo Martínez-Martín3,6, Jose Carlos Martínez-Ávila7, Agustín Gómez de la Cámara7, Luca Giancardo4,8, Teresa Arroyo Gallego9,10,11, Paloma Montero2,12, Verónica Puertas-Martín2, Ignacio Obeso1, Ian Butterworth4, Carlos S Mendoza4, Maria José Catalán12, José Antonio Molina2, Félix Bermejo-Pareja2, Juan Carlos Martínez-Castrillo13, Lydia López-Manzanares14, Araceli Alonso-Cánovas13, Jaime Herreros Rodríguez15, Martha Gray4,10.   

Abstract

Keywords:  Drug Monitoring; Minimal Clinically Important Difference; Parkinson Disease; Pragmatic Clinical Trials; Treatment Outcome

Year:  2018        PMID： 30838303      PMCID： PMC6336372          DOI： 10.1002/mdc3.12632

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  8 in total

1.  Defining a minimal clinically relevant difference for the unified Parkinson's rating scale: an important but still unmet need.

Authors:  Olivier Rascol
Journal:  Mov Disord       Date:  2006-08       Impact factor: 10.338

Review 2.  Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.

Authors:  Dennis Revicki; Ron D Hays; David Cella; Jeff Sloan
Journal:  J Clin Epidemiol       Date:  2007-08-03       Impact factor: 6.437

3.  Satisfaction with Life Scale (SLS-6): First validation study in Parkinson's disease population.

Authors:  Leire Ambrosio; Mari Carmen Portillo; Carmen Rodriguez-Blazquez; Juan Carlos Martínez-Castrillo; Mayela Rodriguez-Violante; Marcos Serrano-Dueñas; Víctor Campos-Arillo; Nelida Susana Garretto; Tomoko Arakaki; Mario Álvarez; Ivonne Pedroso-Ibáñez; Ana Carvajal; Pablo Martinez-Martin
Journal:  Parkinsonism Relat Disord       Date:  2016-02-15       Impact factor: 4.891

4.  Minimal clinically important change on the unified Parkinson's disease rating scale.

Authors:  Anette Schrag; Cristina Sampaio; Nicholas Counsell; Werner Poewe
Journal:  Mov Disord       Date:  2006-08       Impact factor: 10.338

5.  Determination of minimal clinically important change in early and advanced Parkinson's disease.

Authors:  Robert A Hauser; Peggy Auinger
Journal:  Mov Disord       Date:  2011-03-24       Impact factor: 10.338

Review 6.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

Authors:  Claire L Tomlinson; Rebecca Stowe; Smitaa Patel; Caroline Rick; Richard Gray; Carl E Clarke
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

7.  The clinically important difference on the unified Parkinson's disease rating scale.

Authors:  Lisa M Shulman; Ann L Gruber-Baldini; Karen E Anderson; Paul S Fishman; Stephen G Reich; William J Weiner
Journal:  Arch Neurol       Date:  2010-01

8.  The Clinical Impression of Severity Index for Parkinson's Disease: international validation study.

Authors:  Pablo Martínez-Martín; Carmen Rodríguez-Blázquez; Maria João Forjaz; Jesús de Pedro
Journal:  Mov Disord       Date:  2009-01-30       Impact factor: 10.338
  8 in total
  4 in total

1.  Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.

Authors:  Whitley W Aamodt; Teresa Waligorska; Junchao Shen; Thomas F Tropea; Andrew Siderowf; Daniel Weintraub; Murray Grossman; David Irwin; David A Wolk; Sharon X Xie; John Q Trojanowski; Leslie M Shaw; Alice S Chen-Plotkin
Journal:  Mov Disord       Date:  2021-09-04       Impact factor: 10.338

2.  Alexithymia Is Associated with Reduced Quality of Life and Increased Caregiver Burden in Parkinson's Disease.

Authors:  Martin Klietz; Theresa Schnur; Simon C Drexel; Florian Lange; Lejla Paracka; Meret K Huber; Dirk Dressler; Günter U Höglinger; Florian Wegner
Journal:  Brain Sci       Date:  2020-06-24

3.  Blinded Versus Unblinded Evaluations of Motor Scores in Patients with Parkinson's Disease Randomized to Deep Brain Stimulation or Best Medical Therapy.

Authors:  Gun-Marie Hariz; Anna Fredricks; Rasmus Stenmark-Persson; Marwan Hariz; Lars Forsgren; Patric Blomstedt
Journal:  Mov Disord Clin Pract       Date:  2021-01-13

4.  Boxing vs Sensory Exercise for Parkinson's Disease: A Double-Blinded Randomized Controlled Trial.

Authors:  Kishoree Sangarapillai; Benjamin M Norman; Quincy J Almeida
Journal:  Neurorehabil Neural Repair       Date:  2021-06-13       Impact factor: 3.919
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.